Toxicology of antimicrobial nanoparticles for prosthetic devices

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 3999-4006

  Nuñez Anita, Rosa Elvira ^a   Acosta Torres, Laura Susana ^b   Vilar Pineda, Jorge ^b   Martínez Espinosa, Juan Carlos ^c   de la Fuente Hernández, Javier ^b   Castaño, Víctor Manuel ^d  

^a UNIVERSIDAD MICHOACANA DE SAN NICOLÁS DE HIDALGO   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^d CENTRO DE FÍSICA APLICADA Y TECNOLOGÍA AVANZADA   (Mexico)

Author keywords

Antifungal effect; Cytotoxicity; Dentistry; Denture bases; Genotoxicity; Oxidative stress

Indexed keywords

COPPER NANOPARTICLE; GOLD NANOPARTICLE; IRON OXIDE NANOPARTICLE; MAGNESIUM NANOPARTICLE; NANOPARTICLE; SILVER NANOPARTICLE; TITANIUM DIOXIDE NANOPARTICLE; UNCLASSIFIED DRUG; ZINC OXIDE NANOPARTICLE; ANTIINFECTIVE AGENT; BIOMATERIAL;

ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; CANDIDA ALBICANS; CELL VIABILITY; CYTOTOXICITY; DENTISTRY; DENTURE BASE; DENTURE LINER; FUNGUS GROWTH; GENOTOXICITY; HUMAN; IN VITRO STUDY; NANOTECHNOLOGY; NANOTOXICOLOGY; NONHUMAN; OXIDATIVE STRESS; PHYSICAL CHEMISTRY; REVIEW; STREPTOCOCCUS MUTANS; TOOTH PROSTHESIS; ANIMAL; CELL LINE; DENTURE; PROSTHESES AND ORTHOSES; RAT; TOXICITY TESTING;

ANIMALS; ANTI-INFECTIVE AGENTS; BIOCOMPATIBLE MATERIALS; CELL LINE; DENTURES; HUMANS; NANOPARTICLES; OXIDATIVE STRESS; PROSTHESES AND IMPLANTS; RATS; TOXICITY TESTS;

EID: 84929990105     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S63064     Document Type: Review

References (87)

1. Chakraborty M, Jain S, Rani V. Nanotechnology: emerging tool for diagnostics and therapeutics. Appl Biochem Biotechnol. 2011;165(5-6):1178-1187.
2. Chithrani BD, Ghazani AA, Chan WC. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 2006;6(4):662-668.
3. Sperling RA, Rivera Gil P, Zhang F, Zanella M, Parak WJ. Biological applications of gold nanoparticles. Chem Soc Rev. 2008;37(9):1896-1908.
4. Cai W, Gao T, Hong H, Sun J. Applications of gold nanoparticles in cancer nanotechnology. Nanotechnol Sci Appl. 2008;1:17-32.
5. Kohler N, Sun C, Wang J, Zhang M. Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells. Langmuir. 2005;21(19):8858-8864.
6. Gómez LG. Nanopartículas de plata: tecnología para su obtención, caracterización y actividad biológica [Silver nanoparticles: technology for their production, characterization and biological activity]. Investigación en Discapacidad. 2013;2:18-22. Spanish.
7. Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev. 2003;55(3):329-347.
8. Yang PH, Sun X, Chiu JF, Sun H, He QY. Transferrin-mediated gold nanoparticle cellular uptake. Bioconjug Chem. 2005;16(3):494-496.
9. Lövestam GH, Rauscher H, Roebben G, et al. JRC Reference Reports: Considerations on a Definition of Nanomaterial for Regulatory Purposes. JRC Reference Reports. JRC58726. Publications Office of the European Union; 2010. Available from: http://www.wtec.org/nano2/. Accessed July 3, 2014.
10. Williams DF. On the mechanisms of biocompatibility. Biomaterials. 2008;29(20):2941-2953.
11. Kurek A, Grudniak AM, Kraczkiewicz-Dowjat A, Wolska KI. New antibacterial therapeutics and strategies. Pol J Microbiol. 2011;60(1):3-12.
12. Diana V, Bossolasco P, Moscatelli D, Silani V, Cova L. Dose dependent side effect of superparamagnetic iron oxide nanoparticle labeling on cell motility in two fetal stem cell populations. PLoS One. 2013;8(11):e78435.
13. Albrecht MA, Evans CW, Raston CL. Green chemistry and the health implications of nanoparticles. Green Chem. 2006;8(5):417-432.
14. Oberdörster G, Sharp Z, Atudorei V, et al. Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol. 2004;16(6-7):437-445.
15. Lipovsky A, Nitzan Y, Gedanken A, Lubart R. Antifungal activity of ZnO nanoparticles - the role of ROS mediated cell injury. Nanotechnology. 2011;22(10):105101.
16. Manke A, Wang L, Rojanasakul Y. Mechanisms of nanoparticle-induced oxidative stress and toxicity. Biomed Res Int. 2013;2013:942916.
17. Sun RW, Chen R, Chung NP, Ho CM, Lin CL, Che CM. Silver nanoparticles fabricated in Hepes buffer exhibit cytoprotective activities toward HIV-1 infected cells. Chem Commun (Camb). 2005;(40):5059-5061.
18. Durnev AD. Toxicology of nanoparticles. Bull Exp Biol Med. 2008;145(1):72-74.
19. Muller J, Huaux F, Moreau N, et al. Respiratory toxicity of multi-wall carbon nanotubes. Toxicol Appl Pharmacol. 2005;207(3):221-231.
20. Yang H, Liu C, Yang D, Zhang H, Xi Z. Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: the role of particle size, shape and composition. J Appl Toxicol. 2009;29(1):69-78.
21. Zhang T, Wang L, Chen Q, Chen C. Cytotoxic potential of silver nanoparticles. Yonsei Med J. 2014;55(2):283-291.
22. Gliga AR, Skoglund S, Wallinder IO, Fadeel B, Karlsson HL. Size-dependent cytotoxicity of silver nanoparticles in human lung cells: the role of cellular uptake, agglomeration and Ag release. Part Fibre Toxicol. 2014;11:11.
23. Liu W, Wu Y, Wang C, et al. Impact of silver nanoparticles on human cells: effect of particle size. Nanotoxicology. 2010;4(3):319-330.
24. Nel A, Xia T, Mädler L, Li N. Toxic potential of materials at the nanolevel. Science. 2006;311(5761):622-627.
25. Xia T, Kovochich M, Brant J, et al. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett. 2006;6(8):1794-1807.
26. Asharani PV, Hande MP, Valiyaveettil S. Anti-proliferative activity of silver nanoparticles. BMC Cell Biol. 2009;10(1):65.
27. AshaRani PV, Low Kah Mun G, Hande MP, Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano. 2009;3(2):279-290.
28. Foldbjerg R, Dang DA, Autrup H. Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549. Arch Toxicol. 2011;85(7):743-750.
29. Foldbjerg R, Olesen P, Hougaard M, Dang DA, Hoffmann HJ, Autrup H. PVP-coated silver nanoparticles and silver ions induce reactive oxygen species, apoptosis and necrosis in THP-1 monocytes. Toxicol Lett. 2009;190(2):156-162.
30. Hackenberg S, Scherzed A, Kessler M, et al. Silver nanoparticles: evaluation of DNA damage, toxicity and functional impairment in human mesenchymal stem cells. Toxicol Lett. 2011;201(1):27-33.
31. Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro. 2005;19(7):975-983.
32. Piao MJ, Kang KA, Lee IK, et al. Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis. Toxicol Lett. 2011;201(1):92-100.
33. Jin C, Tang Y, Yang FG, et al. Cellular toxicity of TiO2 nanoparticles in anatase and rutile crystal phase. Biol Trace Elem Res. 2011;141(1-3):3-15.
34. Shukla RK, Sharma V, Pandey AK, Singh S, Sultana S, Dhawan A. ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells. Toxicol In Vitro. 2011;25(1):231-241.
35. Voinov MA, Sosa Pagán JO, Morrison E, Smirnova TI, Smirnov AI. Surface-mediated production of hydroxyl radicals as a mechanism of iron oxide nanoparticle biotoxicity. J Am Chem Soc. 2011;133(1):35-41.
36. Xue C, Liu W, Wu J, Yang X, Xu H. Chemoprotective effect of N-acetylcysteine (NAC) on cellular oxidative damages and apoptosis induced by nano titanium dioxide under UVA irradiation. Toxicol In Vitro. 2011;25(1):110-116.
37. Abe K, Matsuki N. Measurement of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction activity and lactate dehydrogenase release using MTT. Neurosci Res. 2000;38(4):325-329.
38. Roehm NW, Rodgers GH, Hatfield SM, Glasebrook AL. An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J Immunol Methods. 1991;142(2):257-265.
39. Belyanskaya L, Manser P, Spohn P, Bruinink A, Wick P. The reliability and limits of the MTT reduction assay for carbon nanotubes-cell interaction. Carbon N Y. 2007;45(13):2643-2648.
40. Kroll A, Pillukat MH, Hahn D, Schnekenburger J. Current in vitro methods in nanoparticle risk assessment: limitations and challenges. Eur J Pharm Biopharm. 2009;72(2):370-377.
41. Simon PL. Cancer Cell Culture: Methods and Protocols. In: Jane AP, editor. Cell sensitivity assay: the MTT. New Jersey: Humana Press Inc; 2002:165-169.
42. Qu QL, Zhang YG. Cytotoxic effects of activated carbon nanoparticles, silicon dioxide nanoparticles and titanium dioxide nanoparticles on human gastric carcinoma cell line BGC-823. Chinese Journal of Pharmacology and Toxicology. 2010;24:481-487.
43. Gurr JR, Wang AS, Chen CH, Jan KY. Ultrafine titanium dioxide particles in the absence of photoactivation can induce oxidative damage to human bronchial epithelial cells. Toxicology. 2005;213(1-2):66-73.
44. Long TC, Saleh N, Tilton RD, Lowry GV, Veronesi B, Titanium dioxide (P25) produces reactive oxygen species in inmortalized brain microglia (BV2): implications for nanoparticle neurotoxicity. 2006;40(14):4346-4352.
45. Kato T, Loo BH, Yokomaku M, Butsugan Y, Sim KY, Fujishima A. Photoelectrochemical reduction of tetrazolium salts to formazans on surfaces of semiconductor powders in alcohol solutions. Spectrosc Lett. 1995;28(6):849-859.
46. Marques EP, Zhang J, Tse YH, Metcalfe RA, Pietro WJ, Lever ABP. Surface electrochemistry of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide ([MTT]Br) adsorbed on a graphite electrode. J Electroanal Chem (Lausanne Switz). 1995;395(1-2):133-142.
47. Acosta-Torres LS, Nunez-Anita RE, Vanegas-Lancon R, de la Fuente J, Lopez-Marin LM, Castano VM. Nanoengineering of dental materials: applications to prosthetics. Recent Pat Nanomed. 2013;3(1):2-8.
48. Bhola R, Bhola SM, Liang H, Mishra B. Biocompatible denture polymers - a review. Trends Biomater Artif Organs. 2010;23(3): 129-136.
49. Acosta-Torres LS, López-Marín LM, Núñez-Anita RE, Hernández-Padrón G, Castaño VM. Biocompatible metal-oxide nanoparticles: nanotechnology improvement of conventional prosthetic acrylic resins. J Nanomater. 2011;2011:941561.
50. Acosta-Torres LS, Mendieta I, Nuñez-Anita RE, Cajero-Juárez M, Castaño VM. Cytocompatible antifungal acrylic resin containing silver nanoparticles for dentures. Int J Nanomedicine. 2012;7:4777-4786.
51. Elsaka SE, Hamouda IM, Swain MV. Titanium dioxide nanoparticles addition to a conventional glass-ionomer restorative: influence on physical and antibacterial properties. J Dent. 2011;39(9):589-598.
52. Muñoz-Bonilla A, Fernández-García M. Polymeric materials with antimicrobial activity. Prog Polym Sci. 2012;37(2):281-339.
53. Minagi S, Miyake Y, Inagaki K, Tsuru H, Suginaka H. Hydrophobic interaction in Candida albicans and Candida tropicalis adherence to various denture base resin materials. Infect Immun. 1985;47(1):11-14.
54. Zamperini CA, Machado AL, Vergani CE, Pavarina AC, Giampaolo ET, da Cruz NC. Adherence in vitro of Candida albicans to plasma treated acrylic resin. Effect of plasma parameters, surface roughness and salivary pellicle. Arch Oral Biol. 2010;55(10):763-770.
55. Zhang L, He R, Gu HC. Synthesis and kinetic shape and size evolution of magnetite nanoparticles. Mater Res Bull. 2006;41(2):260-267.
56. Goffeau A. Drug resistance: the fight against fungi. Nature. 2008;452(7187):541-542.
57. Hannig M, Hannig C. Nanomaterials in preventive dentistry. Nat Nanotechnol. 2010;5(8):565-569.
58. Murray PE, Garcia-Godoy F, Hargreaves KM. Regenerative endodontics: a review of current status and a call for action. J Endod. 2007;33(4):377-390.
59. Uskoković V, Bertassoni LE. Nanotechnology in dental sciences: moving towards a finer way of doing dentistry. Materials (Basel). 2010;3(3):1674-1691.
60. Beyth N, Yudovin-Farber I, Weiss EI, Domb AJ. Antimicrobial nanoparticles in restorative composites. In: Subramani K, Ahmed W, editors. Emerging Nanotechnologies in Dentistry: Materials, Processes and Applications. Oxford, UK: Elsevier Inc; 2012:35-47.
61. Kim JS, Yoon TJ, Yu KN, et al. Toxicity and tissue distribution of magnetic nanoparticles in mice. Toxicol Sci. 2006;89(1):338-347.
62. Kim TH, Kim M, Park HS, Shin US, Gong MS, Kim HW. Size-dependent cellular toxicity of silver nanoparticles. J Biomed Mater Res A. 2012;100(4):1033-1043.
63. Carlson C, Hussain SM, Schrand AM, et al. Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J Phys Chem B. 2008;112(43):13608-13619.
64. Park MV, Neigh AM, Vermeulen JP, et al. The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles. Biomaterials. 2011;32(36):9810-9817.
65. Haase A, Rott S, Mantion A, et al. Effects of silver nanoparticles on primary mixed neural cell cultures: uptake, oxidative stress and acute calcium responses. Toxicol Sci. 2012;126(2):457-468.
66. Lankoff A, Sandberg WJ, Wegierek-Ciuk A, et al. The effect of agglomeration state of silver and titanium dioxide nanoparticles on cellular response of HepG2, A549 and THP-1 cells. Toxicol Lett. 2012;208(3):197-213.
67. Chen X, Schluesener HJ. Nanosilver: a nanoproduct in medical application. Toxicol Lett. 2008;176(1):1-12.
68. Hansen SF, Baun A. When enough is enough. Nat Nanotechnol. 2012;7(7):409-411.
69. Johnston HJ, Hutchison G, Christensen FM, Peters S, Hankin S, Stone V. A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Crit Rev Toxicol. 2010;40(4):328-346.
70. Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv. 2009;27(1):76-83.
71. Stensberg MC, Wei Q, Mclamore ES, Porterfield DM, Wei A, Sepulveda MS. Toxicological studies on silver nanoparticles: challenges and opportunities in assessment, monitoring and imaging. Nanomedicine. 2012;6(5):879-898.
72. Varner K. Scientific, Technical, Research, Engineering and Modeling Support Final Report. State of the Science Literature Review: Everything Nanosilver and More. Washington, DC: US Environmental Protection Agency Office of Research and Development; 2010. Available from: http://www.epa.gov/nanoscience/files/NanoPaper1.pdf. Accessed July 1, 2014.
73. Sivolella S, Stellini E, Brunello G, et al. Silver nanoparticles in alveolar bone surgery devices. J Nanomater. 2012;2012:975842.
74. Driscoll TJ, Lawandy NM, Nouri M, Yoo D, Ronn AM. Conference on Lasers and Electro-Optics; 1997 May 18-23; Baltimore, MD, USA: Optical Society of America.
75. Salata O. Applications of nanoparticles in biology and medicine. J Nanobiotechnology. 2004;2(1):3.
76. Contado C, Pagnoni A. TiO2 in commercial sunscreen lotion: flow field-flow fractionation and ICP-AES together for size analysis. Anal Chem. 2008;80(19):7594-7608.
77. Guo Y, Zhou Y, Jia D, Meng Q. Fabrication and in vitro characterization of magnetic hydroxycarbonate apatite coatings with hierarchically porous structures. Acta Biomater. 2008;4(4):923-931.
78. Sikong L, Kooptarnond K, Niyomwas S, Damchan J. Photoactivity and hydrophilic property of SiO2 and SnO2 co-doped TiO2 nano-composite thin films. Songklanakarin Journal of Science & Technology. 2010;32(4):413-418.
79. Arbab AS, Bashaw LA, Miller BR, et al. Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology. 2003;229(3):838-846.
80. Sanpo N, Wen C, Berndt CC, Wang J. Antibacterial properties of spinel ferrite nanoparticles. In: Mendez A, editor. Microbial pathogens and strategies for combating them: science, technology and education. Spain: Formatex Research Centre. 2013:239-250.
81. Limbach LK, Wick P, Manser P, Grass RN, Bruinink A, Stark WJ. Exposure of engineered nanoparticles to human lung epithelial cells: influence of chemical composition and catalytic activity on oxidative stress. Environ Sci Technol. 2007;41(11):4158-4163.
82. Niño-Martínez N, Martínez-Castañón GA, Aragón-Piña A, Martínez-Gutierrez F, Martínez-Mendoza JR, Ruiz F. Characterization of silver nanoparticles synthesized on titanium dioxide fine particles. Nanotechnology. 2008;19(6):065711.
83. Ahn SJ, Lee SJ, Kook JK, Lim BS. Experimental antimicrobial orthodontic adhesives using nanofillers and silver nanoparticles. Dent Mater. 2009;25(2):206-213.
84. McCord JF, Grant AA. Pre-definitive treatment: rehabilitation prostheses. BDJ. 2000;8:419-424.
85. Pereira-Cenci T, Del Bel Ccry AA, Crielaard W, Ten Cate JM. Development of Candida-associated denture stomatitis: New insights. J Appl Oral Sci. 2008;16(2):86-94.
86. Pavan S, dos Santos PH, Filho JN, Spolidorio DM. Colonisation of soft lining materials by micro-organisms. Gerodontology. 2010;27(3):211-216.
87. Reidy B, Haase A, Luch A, Dawson KA, Lynch I. Mechanisms of Silver Nanoparticle Release, Transformation and Toxicity: A Critical Review of Current Knowledge and Recommendations for Future Studies and Applications. Materials 2013;6:2295-2350.